Press Release FeedGet the RSS feed
Menu

Business Wire

Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program

Business Wire

  • Global clinical studies advance Cochlear's fully implantable hearing technology

  • US, European and Australian pivotal trial recruitment completed, and more than 100 people implanted across the full research program

  • Program reflects Cochlear's evidence-led approach to developing breakthrough technology focused on all-day hearing and implant battery longevity, surgical familiarity, microphone performance and trust through experience and evidence

SYDNEY, September 28, 2026--Cochlear today announced the completion of recruitment for the worldwide pivotal trial program evaluating fully implantable hearing technology. Patients across Cochlear's fully implantable hearing system research programs have experienced more than 1 million hours with their device to date.

This reflects the most comprehensive research program focused on fully implantable hearing technology, underscoring Cochlear's long-term commitment to this new category. Through a rigorous, evidence-led clinical program, Cochlear is building a deeper understanding of the features, performance and outcomes that matter most to recipients, clinicians and health systems.

Cochlear said its global research program continues to progress, with recruitment completed in the ELEVATE study across 11 sites in the US and in the ENTERPRISE study across five sites in Europe and Australia. Ongoing follow-up of the 92 patients in these studies and data collection activities will continue as Cochlear advances its development program towards regulatory submissions.1 Including previous feasibility studies dating back to 2005, more than 100 patients have received Cochlear fully implantable hearing technology.1-4

"Fully implantable technology represents an exciting future direction for hearing care. We now have more than 20 years of experience across three generations of investigational devices. This has given us a strong understanding of what recipients and clinicians need in everyday life. We're committed to delivering meaningful real-world benefits for recipients," said Dig Howitt, Cochlear's chief executive officer and president.

Cochlear said lessons gained through three generations of development have highlighted four critical patient and clinician needs for future fully implantable hearing technology:

  • All-day hearing performance in everyday environments and implant battery longevity

  • Internal dual-microphone technology designed for body noise cancellation, surgical simplicity and streamlined programming

  • A familiar surgical technique to minimize additional theatre and anesthesia time

  • Confidence based on long-term clinical data, recipient insights and a large evidence base

  1. SaaSThe Prostate Cancer FoundationProstate Cancer Foundation Expands Radiopharmaceutical Think Tank as Field Enters Pivotal Growth Phase– PCF Think Tank aims to increase adoption of radiopharmaceuticals as major oncology therapeutic platform in prostate cancer treatment and to other tumor types – – New members Orano Med, Telix and Siemens Healthineers join PCF and industry leaders at kickoff meeting at 2026 EANM Annual Congress to address key challenges i
  2. FinanceAlign Technology, Inc.Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent CourtCompanies: Align TechnologySAN JOSE, Calif. & TEMPE, Ariz., October 17, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, welcomes the decision of the Unified Patent Court ("UPC") finding that aligner syst
  3. AISyncra and Neumetry Partner to Build AI-Powered Readiness Platform for Teenage Athletes and Their CoachesSmart ring data meets FDA-cleared physiological AI to help coaches see which athletes are ready to compete, and which need rest LAS VEGAS & SAN JOSE, Calif., October 17, 2026--Syncra Labs Inc., maker of the Syncra smart ring, and Neumetry Medical, Inc., developer of an FDA-cleared predictive health pla
  4. HealthcareAIDS Healthcare FoundationAHF Commemorates 40 Years of Global Impact During Annual World AIDS Day Concert Celebration Featuring Ricky MartinLOS ANGELES, October 16, 2026--AIDS Healthcare Foundation (AHF) , the world's largest, non-profit public health organization providing direct HIV/ADS services to over 3.3 million clients across the globe, will celebrate 40 years of impact during its annual World AIDS Day concert commemoration. Continu
  5. Real estateKBRA Assigns Preliminary Ratings to Angel Oak Mortgage Trust 2026-6 (AOMT 2026-6)NEW YORK, October 16, 2026--KBRA assigns preliminary ratings to ten classes of mortgage-backed certificates from Angel Oak Mortgage Trust 2026-6 (AOMT 2026-6), a $250.6 million non-prime RMBS transaction. The underlying collateral, comprised of 381 residential mortgages, and includes a meaningful conce
  6. FinanceUL SolutionsUL Solutions Warns of GFCI and Duplex Wall Outlets Modified by Third Parties to Include Built-in CamerasAfter manufacturing, third parties added built-in cameras to the wall outlets; UL Solutions did not evaluate the modified products and recommends that they be immediately removed from service and discarded. NORTHBROOK, Ill., October 16, 2026--UL Solutions (NYSE: ULS), a global leader in applied safety